Pharmacopuncture Effects on Insomnia Disorder: Protocol for a Multi-Site, Randomized, Acupuncture-Controlled, Clinical Trial.
Jung-Hwa LimJae-Hyok LeeChan-Young KwonSang-Hyup LeeChang Wan KangEun ChoHyun-Woo KimJun-Hee ChoBo-Kyung KimPublished in: International journal of environmental research and public health (2022)
Insomnia is a common health problem that can lead to various diseases and negatively impact quality of life. Pharmacopuncture is a new type of acupuncture that involves applying herbal medicine extracts to acupoints. Korean medicine doctors frequently use it to treat insomnia disorder. However, there is insufficient evidence to support the effectiveness and safety of pharmacopuncture for insomnia disorder. We designed a pragmatic randomized controlled trial to compare the effectiveness of pharmacopuncture and acupuncture for insomnia disorder. This multi-site, randomized, acupuncture-controlled trial will enroll 138 insomnia patients. The subjects will be randomly assigned to one of two groups, pharmacopuncture or acupuncture, at a 2:1 ratio. For 4 weeks, the participants will receive ten sessions of pharmacopuncture or acupuncture treatment and will be followed up for 4 weeks after the treatment ends. The Pittsburgh Sleep Quality Index score is the primary outcome measure. Insomnia severity index score, sleep parameters recorded using actigraphy and sleep diaries, physical symptoms associated with insomnia, emotions, quality of life, medical costs, and safety are the secondary outcome measures. The findings of this trial willprovide evidence that will be useful in clinical decision-making for insomnia treatment strategies.
Keyphrases
- sleep quality
- randomized controlled trial
- depressive symptoms
- physical activity
- study protocol
- clinical trial
- double blind
- open label
- phase iii
- healthcare
- phase ii
- systematic review
- decision making
- public health
- mental health
- placebo controlled
- ejection fraction
- risk assessment
- combination therapy
- health information
- human health
- patient reported